<DOC>
	<DOCNO>NCT02256605</DOCNO>
	<brief_summary>The purpose prospecitve randomize control trial compare effectiveness patient/family adherence weekly daily Vitamin D-3 dosing regimens child Inflammatory Bowel Disease ( IBD ) 25-hydroxyvitamin D [ 25 ( OH ) D ] insufficient deficient . The primary aim pilot study evaluate effectiveness weekly verse daily D-3 dosing regimen base current IBD supplementation guideline improve 25 ( OH ) D level . A seconary aim determine difference adherence dose regimns .</brief_summary>
	<brief_title>Vitamin D3 Supplementation Pediatric IBD : Weely v Daily Dosing Regimens</brief_title>
	<detailed_description />
	<mesh_term>Inflammatory Bowel Diseases</mesh_term>
	<mesh_term>Vitamins</mesh_term>
	<mesh_term>Vitamin D</mesh_term>
	<mesh_term>Ergocalciferols</mesh_term>
	<mesh_term>Cholecalciferol</mesh_term>
	<criteria>Subjects age 5 17 year diagnosis Inflammatory Bowel Disease , 25 ( OH ) D level 30 ng/ml within 2 week enrollment Subject/family must able willing take oral medication , complete 3 day dietary record , return 8 week conclude visit clinicl visit Subjects eligible intolerant vitamin supplementation ingredient choose supplment , unable unwilling take oral supplement , specific medical therapy diminish bone mineral density Children parathryoid disease , granulomatous disorder William 's syndrome also exclude study</criteria>
	<gender>All</gender>
	<minimum_age>5 Years</minimum_age>
	<maximum_age>17 Years</maximum_age>
	<verification_date>May 2015</verification_date>
</DOC>